Di Stadio, A.; Bernitsas, E.; La Mantia, I.; Brenner, M.J.; Ralli, M.; Vaira, L.A.; Colizza, A.; Cavaliere, C.; Laudani, M.; Frohman, T.C.;
et al. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)? Life 2023, 13, 226.
https://doi.org/10.3390/life13010226
AMA Style
Di Stadio A, Bernitsas E, La Mantia I, Brenner MJ, Ralli M, Vaira LA, Colizza A, Cavaliere C, Laudani M, Frohman TC,
et al. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)? Life. 2023; 13(1):226.
https://doi.org/10.3390/life13010226
Chicago/Turabian Style
Di Stadio, Arianna, Evanthia Bernitsas, Ignazio La Mantia, Michael J. Brenner, Massimo Ralli, Luigi Angelo Vaira, Andrea Colizza, Carlo Cavaliere, Matteo Laudani, Teresa C. Frohman,
and et al. 2023. "Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?" Life 13, no. 1: 226.
https://doi.org/10.3390/life13010226
APA Style
Di Stadio, A., Bernitsas, E., La Mantia, I., Brenner, M. J., Ralli, M., Vaira, L. A., Colizza, A., Cavaliere, C., Laudani, M., Frohman, T. C., De Vincentiis, M., Frohman, E. M., & Altieri, M.
(2023). Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)? Life, 13(1), 226.
https://doi.org/10.3390/life13010226